Elkridge, MD. April 23, 2008 — Global performance improvement solutions provider General Physics Corporation (GP), the operating subsidiary of GP Strategies Corporation (NYSE: GPX), announced the launch of a new series of life science compliance online training courses to address compliance needs in the pharmaceutical and biotechnical industries.
This Life Science compliance offering is both flexible and affordable because courses can be accessed through the GPiLearn Rx learning portal, or they can be licensed for use in a customer’s enterprise learning management system. GP can also customize the on-line courses using a wide variety of authoring tools to meet specific client preferences.
Sheri Winter, Director of Life Sciences Business Development for GP, views this course offering “as a highly desirable regulatory solution that provides our customers a compelling choice in the compliance training arena with flexible and customizable alternatives that are presently not available in the marketplace.”
Course topics include Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP), as well as other topics required by the U.S. Food and Drug Administration (FDA).
General Physics Corporation, the principal operating subsidiary of GP Strategies Corporation (NYSE:GPX), is a global provider of sales and technical training, e-learning solutions, management consulting, and engineering services. GP’s solutions improve the effectiveness of organizations by delivering innovative and superior training, consulting, and business improvement services customized to meet the specific needs of its clients. Clients include Fortune 500 companies, manufacturing, process and energy industries, and other commercial and government customers. Additional information may be found about General Physics Corporation at www.gpworldwide.com.
We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements reflect our current expectations concerning future events and results. We use words such as “expect,” “intend,” “believe,” “may,” “will,” “should,” “could,” “anticipates,” and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project. For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the forward-looking statements and risk factors sections. Except as required by law, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Scott N. Greenberg
Chief Executive Officer
Chief Financial Officer